The work, which was led by Duchen lab PhD student Chih-Yao Chung, highlights the role of dysfunctional cell signaling pathways associated with a mtDNA mutation that causes the disease ‘MELAS’ for which there is no treatment. We have shown that bioenergetic function can be rescued by drugs which inhibit those signaling pathways, suggesting possible novel therapeutic approaches.
Chih-Yao Chung (centre) with Will Kotiadis who started the work (left) and Nicoletta Plotegher (right)
Read the Open Access article at: https://www.nature.com/articles/s41467-021-26746-2
UCL academic appointed Chair of £6 million NHS Commission for National Autism Peer Programme
Dr Georgia Pavlopoulou has been appointed Chair of the NHS Commission for the National Autism Peer Programme, Autism Central, after leading a successful £6 million bid.
12 Nov 2025
UCL GBSH leads £1m international project to reimagine Indigenous health systems in India
A new NIHR-funded project led by UCL’s Global Business School for Health will work with Indigenous Adivasi communities in southern India to co-design culturally responsive health systems.
12 Nov 2025
UCL Research Department Away Day enjoyed at UCL East
CDB were at UCL East on Friday, 07 November 2026, and enjoyed the site facilities - including the AcelorMittal Orbit - plus many short research reports, strategy discussions, a quiz and socialising.
11 Nov 2025